10 Results

People

  1. Scher
    Scher
  2. Scardino
    Scardino
  3. Hricak
    Hricak
  4. Eastham
    Eastham
  5. Schoder
    Schoder
  6. Dotan
    Dotan
  7. Larson
    Larson
  8. Lilja
    Lilja
  9. Bianco
    Bianco
  10. Chen
    Chen

Groups

  1. Department of Medicine (10)
  2. Genitourinary Oncology Service (10)
  3. Molecular Imaging and Therapy Service (10)
  4. Molecular Pharmacology and Chemistry Program Faculty (10)
  5. Sloan Kettering Institute Faculty (10)
  6. Solid Tumor Oncology Division (10)
  7. Surgery (10)
  8. Urology (10)
  9. Radiology, Department of (9)
  10. GSK Faculty (8)
  1. "Surgery"
  2. "Solid Tumor Oncology Division"
  3. "Molecular Imaging and Therapy Service"
  4. "Peter Scardino"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (10)
  2. Genitourinary Oncology Service (10)
  3. Molecular Imaging and Therapy Service (10)
  4. Molecular Pharmacology and Chemistry Program Faculty (10)
  5. Sloan Kettering Institute Faculty (10)
  6. Solid Tumor Oncology Division (10)

More Groups

People
  1. Howard Scher (10)
  2. Peter Scardino (10)
  3. Hedvig Hricak (5)
  4. Steven Larson (5)
  5. Heiko Schoder (4)
  6. James Eastham (4)

More People

Years
  1. 2021 (1)
  2. 2018 (1)
  3. 2017 (2)
  4. 2016 (1)
  5. 2006 (1)
  6. 2005 (2)

More Years

Publications
  1. Journal of Clinical Oncology (3)
  2. Clinical Cancer Research (2)
  3. Journal of Urology (1)
  4. Nature Communications (1)
  5. Quarterly Journal of Nuclear Medicine (1)
  6. Science Translational Medicine (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (3)
  2. American Association for Cancer Research (2)
  3. Elsevier Science, Inc. (2)
  4. American Association for the Advancement of Science (1)
  5. Edizioni Minerva Medica (1)
  6. Nature Publishing Group (1)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PSA-targeted alpha-, beta-, and positron-emitting immunotheranostics in murine prostate cancer models and nonhuman primates
    Journal Article

    Veach, D. R.; Storey, C. M.; Lückerath, K.; Braun, K.; von Bodman, C.; Lamminmäki, U.; Kalidindi, T.; Strand, S. E.; Strand, J.; Altai, M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
    Journal Article

    McDevitt, M. R.; Thorek, D. L. J.; Hashimoto, T.; Gondo, T.; Veach, D. R.; Sharma, S. K.; Kalidindi, T. M.; Abou, D. S.; Watson, P. A.; Beattie, B. J.; more...
    Nature Communications (2018)

    Fulltext@MSK | Save
  • A pilot study of a multimodal treatment paradigm to accelerate drug evaluations in early-stage metastatic prostate cancer
    Journal Article

    O'Shaughnessy, M. J.; McBride, S. M.; Vargas, H. A.; Touijer, K. A.; Morris, M. J.; Danila, D. C.; Laudone, V. P.; Bochner, B. H.; Sheinfeld, J.; Dayan, E. S.; more...
    Urology (2017)

    Fulltext@MSK | Save
  • Combined whole body and multiparametric prostate magnetic resonance imaging as a 1-step approach to the simultaneous assessment of local recurrence and metastatic disease after radical prostatectomy
    Journal Article

    Robertson, N. L.; Sala, E.; Benz, M.; Landa, J.; Scardino, P.; Scher, H. I.; Hricak, H.; Vargas, H. A.
    Journal of Urology (2017)

    Fulltext@MSK | Save
  • Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axis
    Journal Article

    Thorek, D. L. J.; Watson, P. A.; Lee, S. G.; Ku, A. T.; Bournazos, S.; Braun, K.; Kim, K.; Sjostrom, K.; Doran, M. G.; Lamminmaki, U.; more...
    Science Translational Medicine (2016)

    Fulltext@MSK | Save
  • The probability of a positive bone scan in patients who were treated with adrogen ablasio therapy for rising PSA after radical prostatectomy
    Meeting Abstract

    Dotan, Z. A.; Sathyamoorthy, K.; Bianco, F. J.; Stephenson, A. J.; Eastham, J. A.; Fearn, P.; Schoder, H.; Scher, H. I.; Scardino, P. T.; Kattan, M. W.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • 2-[ 18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy
    Journal Article

    Schoder, H.; Herrmann, K.; Gonen, M.; Hricak, H.; Eberhardt, S.; Scardino, P.; Scher, H. I.; Larson, S. M.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy
    Journal Article

    Dotan, Z. A.; Bianco, F. J. Jr; Rabbani, F.; Eastham, J. A.; Fearn, P.; Scher, H. I.; Kelly, K. W.; Chen, H. N.; Schoder, H.; Hricak, H.; more...
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • What is the probability of a positive bone scan (+BS) in patients with a rising PSA after radical prostatectomy (RP): A new nomogram
    Meeting Abstract

    Dotan, Z. A.; Kattan, M. W.; Bianco, F. J.; Rabbani, F.; Eastham, J. A.; Scher, H. I.; Chen, H. N.; Schoder, H.; Hricak, H.; Scardino, P. T.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Local detection of prostate cancer by positron emission tomography with 2-fluorodeoxyglucose: Comparison of filtered back projection and iterative reconstruction with segmented attenuation correction
    Journal Article

    Turlakow, A.; Larson, S. M.; Coakley, F.; Akhurst, T.; Gonen, M.; Macapinlac, H. A.; Kelly, W.; Leibel, S.; Humm, J.; Scardino, P.; more...
    Quarterly Journal of Nuclear Medicine (2001)

    Fulltext@MSK | Save